| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 52.61 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.26 |
EPS(TTM) : 36.83 |
|
Book Value(₹) : 182.89 |
Market Cap(₹Cr) : 14,727.27 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 185.64 | 139.38 | 132.83 | 179.22 | 173.66 | 144.67 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 185.64 | 139.38 | 132.83 | 179.22 | 173.66 | 144.67 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 21.50 | 36.18 | 17.90 | 24.49 | 27.27 | 12.22 |
| Total Income | 207.14 | 175.56 | 150.73 | 203.71 | 200.93 | 156.89 |
| Total Expenditure | 104.26 | 81.70 | 69.51 | 89.77 | 97.04 | 79.80 |
| PBIDT | 102.88 | 93.86 | 81.22 | 113.94 | 103.89 | 77.09 |
| Interest | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 |
| PBDT | 102.86 | 93.84 | 81.19 | 113.92 | 103.86 | 77.06 |
| Depreciation | 6.18 | 6.93 | 6.76 | 6.72 | 6.67 | 6.29 |
| Tax | 24.57 | 17.22 | 19.91 | 27.09 | 21.90 | 17.96 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.43 | -0.19 | -0.93 | -1.99 | -0.98 | -1.52 |
| Reported Profit After Tax | 72.54 | 69.88 | 55.45 | 82.10 | 76.27 | 54.33 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 72.54 | 69.88 | 55.45 | 82.10 | 76.27 | 54.33 |
| EPS (Unit Curr.) | 9.55 | 9.20 | 7.30 | 10.82 | 10.04 | 7.15 |
| EPS (Adj) (Unit Curr.) | 9.55 | 9.20 | 7.30 | 10.82 | 10.04 | 7.15 |
| Calculated EPS (Unit Curr.) | 9.54 | 9.20 | 7.30 | 10.81 | 10.04 | 7.16 |
| Calculated EPS (Adj) (Unit Curr.) | 9.54 | 9.20 | 7.30 | 10.81 | 10.04 | 7.16 |
| Calculated EPS (Ann.) (Unit Curr.) | 38.18 | 36.80 | 29.20 | 43.24 | 40.17 | 28.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 38.18 | 36.80 | 29.20 | 43.24 | 40.17 | 28.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 125.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.20 | 15.19 | 15.19 | 15.19 | 15.19 | 15.18 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 55.42 | 67.34 | 61.15 | 63.58 | 59.82 | 53.29 |
| PBDTM(%) | 55.41 | 67.33 | 61.12 | 63.56 | 59.81 | 53.27 |
| PATM(%) | 39.08 | 50.14 | 41.75 | 45.81 | 43.92 | 37.55 |